APA (7th ed.) Citation

Pagis, V., Astouati, Q., Pacoureau, L., Nguyen, Y., Bay, P., Roux, A., . . . Ullmer, A. (2026). Janus kinase and calcineurin‐inhibitor combination in anti‐MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile. Journal of Internal Medicine, 299(2), 228. https://doi.org/10.1111/joim.70047

Chicago Style (17th ed.) Citation

Pagis, Valentine, et al. "Janus Kinase and Calcineurin‐inhibitor Combination in Anti‐MDA5 Dermatomyositis: No Significant Survival Benefit but Reassuring Safety Profile." Journal of Internal Medicine 299, no. 2 (2026): 228. https://doi.org/10.1111/joim.70047.

MLA (9th ed.) Citation

Pagis, Valentine, et al. "Janus Kinase and Calcineurin‐inhibitor Combination in Anti‐MDA5 Dermatomyositis: No Significant Survival Benefit but Reassuring Safety Profile." Journal of Internal Medicine, vol. 299, no. 2, 2026, p. 228, https://doi.org/10.1111/joim.70047.